M

Mission Therapeutics

49 employees

MISSION Therapeutics offers a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes (DUBs).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
drug discovery
Therapeutics
neurodegeneration
cancer
deubiquitylating enzymes
oncology
ubiquitin
Life Science

Date founded

2011

Funding rounds raised

Total raised

$86M

from 15 investors over 15 rounds

M

Mission Therapeutics raised $15M on July 6, 2020

Investors: S.R. One Ltd and Sofinnova Partners

M

Mission Therapeutics raised $15M on July 6, 2020

Investors: Sofinnova Partners, S.R. One Ltd and IP Group plc

M

Mission Therapeutics raised $86M on February 2, 2016

Investors: S.R. One Ltd, Imperial College London, Woodford Investment Management and Sofinnova Partners

M

Mission Therapeutics raised $2.9M on September 25, 2015

Investors: Innovate UK

M

Mission Therapeutics raised $32M on November 18, 2013

Investors: Sofinnova Partners and S.R. One Ltd

M

Mission Therapeutics raised $6M on August 24, 2011

Investors: Imperial College London, S.R. One Ltd and Sofinnova Partners

FAQ